Published in Drug Law Weekly, January 13th, 2009
The acquisition complements Moog's current medical devices product line. "This acquisition is a great fit while broadening our product offering and geographic presence in the infusion therapy market," said Martin Berardi, President of the Medical Devices Group of Moog.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-01-13)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.